Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Accuray Incorporated (ARAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 422,703
  • Shares Outstanding, K 87,880
  • Annual Sales, $ 404,900 K
  • Annual Income, $ -23,900 K
  • 60-Month Beta 2.07
  • Price/Sales 1.01
  • Price/Cash Flow N/A
  • Price/Book 8.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.04
  • Number of Estimates 2
  • High Estimate -0.03
  • Low Estimate -0.05
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.32 +11.47%
on 03/15/19
5.40 -10.93%
on 02/22/19
-0.29 (-5.69%)
since 02/19/19
3-Month
3.16 +51.97%
on 12/26/18
5.40 -10.93%
on 02/22/19
+1.20 (+33.24%)
since 12/19/18
52-Week
3.16 +51.97%
on 12/26/18
5.40 -10.93%
on 02/22/19
-0.49 (-9.25%)
since 03/19/18

Most Recent Stories

More News
Intuitive Surgical da Vinci SP Gets FDA Nod, Prospects Bright

Intuitive Surgical (ISRG) fortifies its foothold in the global robotic-surgery market.

SYK : 196.12 (+1.31%)
ARAY : 4.81 (+3.00%)
VEEV : 124.17 (+1.40%)
ISRG : 562.72 (+0.58%)
Bilkent City Hospital Selects Accuray's Radixact® System

Largest Hospital in Europe Expands Access to Precise Radiation Treatments to More Patients

ARAY : 4.81 (+3.00%)
Varian & Tata Trust Tie Up to Boost Radiotherapy in India

Varian's (VAR) three-year deal with Tata Trust is likely to fortify its foothold in the Asia-Pacific radiotherapy space.

SYK : 196.12 (+1.31%)
VAR : 136.64 (+0.79%)
ARAY : 4.81 (+3.00%)
DXCM : 146.94 (+0.54%)
Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with Localized Prostate Cancer

Data Presented at the 2019 Genitourinary Cancers Symposium Reinforces Benefits of Short Course of Treatment Using Stereotactic Body Radiation Therapy for Low- or Intermediate-Risk Prostate Cancer

ARAY : 4.81 (+3.00%)
Why Is Accuray (ARAY) Up 17% Since Last Earnings Report?

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ARAY : 4.81 (+3.00%)
Cutera Appoints Katherine Zanotti and Joseph Whitters to its Board of Directors

CUTERA, INC., (Nasdaq: CUTR) ("Cutera" or the "Company") a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announced today the appointment of two...

EXAS : 91.15 (-0.85%)
INFU : 4.44 (+1.14%)
PRGX : 8.16 (-0.85%)
ARAY : 4.81 (+3.00%)
CUTR : 17.85 (-0.67%)
Oncology Information System Market to reach to a valuation of US$3,293.8 Mn by 2022, Due to Well-Established Infrastructure - TMR

The competition for global oncology information system market is getting fierce. Companies operating in the market are investing in the development of technologically advanced information systems. Besides...

MCK : 122.52 (+0.95%)
ARAY : 4.81 (+3.00%)
Accuray Inc Up 20.3% Since SmarTrend Uptrend Call (ARAY)

SmarTrend identified an Uptrend for Accuray Inc (NASDAQ:ARAY) on January 23rd, 2019 at $4.37. In approximately 3 weeks, Accuray Inc has returned 20.27% as of today's recent price of $5.25.

ARAY : 4.81 (+3.00%)
Here's Why Investors Should Retain Accuray (ARAY) Stock Now

A series of software upgrades is likely to provide Accuray (ARAY) a competitive edge in the radiation-oncology space.

ABT : 79.96 (+1.43%)
SRDX : 45.67 (-3.97%)
ARAY : 4.81 (+3.00%)
CSII : 39.41 (-0.13%)
Factors of Influence in 2019, Key Indicators and Opportunity within Marathon Oil, Accuray, United Natural Foods, Systemax, Amgen, and NewLink Genetics -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Marathon Oil Corporation...

SYX : 21.27 (+0.09%)
ARAY : 4.81 (+3.00%)
MRO : 17.12 (-1.55%)
UNFI : 13.71 (-0.94%)
AMGN : 191.49 (+0.09%)
NLNK : 2.14 (+13.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade ARAY with:

Business Summary

ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends...

See More

Key Turning Points

2nd Resistance Point 4.97
1st Resistance Point 4.89
Last Price 4.81
1st Support Level 4.68
2nd Support Level 4.55

See More

52-Week High 5.40
Last Price 4.81
Fibonacci 61.8% 4.55
Fibonacci 50% 4.28
Fibonacci 38.2% 4.02
52-Week Low 3.16

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar